Organic compounds -- part of the class 532-570 series – Organic compounds – Carbohydrates or derivatives
Reexamination Certificate
2006-02-21
2006-02-21
McGarry, Sean (Department: 1635)
Organic compounds -- part of the class 532-570 series
Organic compounds
Carbohydrates or derivatives
C536S024500, C536S023100, C514S04400A
Reexamination Certificate
active
07002003
ABSTRACT:
There is provided a method of modulating the function of transcription factor by administering an effective amount of an oligonucleotide containing optimal nucleotide binding sites for the transcription factor. A therapeutic agent having an effective amount of an oligonucleotide for modulating function of transcription factors and a pharmaceutically acceptable carrier is also provided. Also provided is a treatment of patients having illnesses in which the activation of transcription factors play a role by administering to a patient an effective amount of an oligonucleotide which competitively binds the related transcription factor.
REFERENCES:
patent: 4439196 (1984-03-01), Higuchi
patent: 4447224 (1984-05-01), DeCant, Jr.
patent: 4447233 (1984-05-01), Mayfield
patent: 4475196 (1984-10-01), La Zor
patent: 4486194 (1984-12-01), Ferrara
patent: 4487603 (1984-12-01), Harris
patent: 4666828 (1987-05-01), Gusella
patent: 4683202 (1987-07-01), Mullis
patent: 4801531 (1989-01-01), Frossard
patent: 4925678 (1990-05-01), Ranney
patent: 4959217 (1990-09-01), Sanders
patent: 5034506 (1991-07-01), Summerton et al.
patent: 5167616 (1992-12-01), Haak
patent: 5169383 (1992-12-01), Gyory
patent: 5192659 (1993-03-01), Simons
patent: 5225182 (1993-07-01), Sharma
patent: 5272057 (1993-12-01), Smulson
patent: 5712094 (1998-01-01), Seidel et al.
patent: 6448011 (2002-09-01), Bard et al.
patent: WO 95/28482 (1995-10-01), None
Dzau , Victor, Circulation Research, vol. 20, pp. 1234-1236, 2002.
Jen et al., Stem Cells, vol. 18, pp. 307-319, 2000.
Green et al. J. of Am. Coll. Surg. vol. 191, No. 1, Jul. 2000.
Agrawal et al. Molecular Medicine Today, vol. 6, pp. 72-81, Feb. 2000.
Ma et al., Biotechnology Annula Review, vol. 5, pp. 155-196, 2000.
Branch, TIBS 23, pp. 45-50, Feb. 1998.
Flanagan et al., Nature Biotechnology, vol. 17, No. 1, pp. 48-52, Jan. 1999.
Bennett et al. “Pharmacology of Antisense Therapeutic Agents”, Chapter 2, from Methods in Molecular Medicine: Antisense Therapeutics, Ed. S. Agrawal, Humana Press Inc., Totowa, NJ, ISBN: 0—89603-305-8, 1996.
Liu et al. Experimental Hematology, vol. 25, No. 8, p. 764, 1997.
Boccaccio et al., Nature, vol. 391, Jan. 15, 1998, p. 285-288.
Pearse et al., PNAS vol. 90:4313-4318, May 1993.
Wegenka et al., Molecular and Cellular Biology vol. 13(1):276-288, 1993.
Agarwal et al (1996). Antisense oligonucleotides: towards clinical trials, TIBTECH, 14:376.
Ausubel et al. Current Protocols in Molecular Biology, INDEX 1990, Suppl. 13.
Eckstein (1985). Nucleoside Phosphorothioates. Ann. Rev. Biochem. 54:367-402.
Iyer et al. (1990) J. Org. Chem. 55:4693-4699.
Mishell and Shiigi (eds), Selected Methods in Cellular Immunology, pp. 23&24.
Sambrook et al. Molecular Cloning: A Laboratory Manual, Cold Springs Harbor Laboratory, New York (1989, 1992), pp. 16.30-16.56.
Shaw et al (1991). Modified deoxyoligonucleotides stable to exonuclease degradation in serum. Nucleic Acids Res. 19:747-750.
Spitzer and Eckstein (1988). Inhibition of deoxynucleases by phosphorothioate groups in oligodeoxyribonucleotides. Nucleic Acids Res. 18:11691-11704.
Stites et al (eds), Basic and Clinical Immunology (8thEdition).
Taylor (1980) J. Histochem, Cytochem 28:1021.
Testoni et al (1996), Blood 87:3822.
Dusanter-Fourt et al. “Identification of JAK protein tyrosine kinases as signaling molecules for prolactin. Functional analysis of prolactin receptor and prolactin- erythropoietin receptor chimera expressed in lymphoid cells,”The EMBO Journal,1994, vol. 13, No. 11, pp. 2583-2591.
Gewirtz et al. “Nucleic Acid Therapeutics: State of the Art and Future Prospects,”Blood,1998, vol. 92, No. 3, pp. 712-736.
Gorodetsky et al. “Isolation and characterization of theBos Taurus β-caseingene,”Gene,1988, vol. 66, pp. 87-96.
Greenberg et al. “Characterization of a New Megakaryocytic Cell Line: The Dami Cell,”Blood,1988, vol. 72, No. 6, pp. 1968-1977.
Hong et al. “Inhibition of Protein Kinase C Suppresses Megakaryocytic Differentiation and Stimulates Erythroid Differentiation in HEL Cells,”Blood,1996, vol. 87, No. 1, pp. 123-131.
Martin “HEL Cells: A New Human Erythroleukemia Cell Line with Spontaneous and Induced Globin Expression,”Science,1982, vol. 216, pp. 1233-1235.
Ogura et al. “Establishment of a Novel Human Megakaryoblastic Leukemia Cell Line, MEG-01, With Positive Philadelphia Chromosome,”Blood,1985, vol. 66, No. 6, pp. 1384-1392.
Iyer et al. “The Automated Synthesis of Sufur-Containing Oligodeoxyribonucleotides Using 3H-1,2-Benzodithiol-3-one 1,1-Dioxide as a Sulfur-Transfer Reagent,”J. Org. Chem.,1990, vol. 55, pp. 4693-4699.
Woolf et al. “The stability, toxicity and effectiveness of unmodified and phosphorothioate antisense oligodeoxynucleotides in Xenopus oocytes and embryos,”Nucleic Acids Research,1990, vol. 18, No. 7, pp. 1763-1769.
Yu et al. “Attenuation of Serum Inducibility of Immediate Early Genes by Oncoproteins in Tyrosine Kinase Signaling Pathways,”Molecular and Cellular Biology,1993, vol. 13, No. 4, pp. 2011-2019.
Appleton & Lange, Critical Care Diagnosis & Treatment, Edited by Frederic S. Bongard and Darryl Y. Sue, Paramount Publishing Business and Professional Group.
PCR Protocols: A Guide to Methods and Applications, Edited by Michael A. Innis et al., Academic Press, Inc., 1990.
Liu Richard Y.
Zuckerman Kenneth S.
McGarry Sean
Saliwanchik Lloyd & Saliwanchik
University of South Florida
LandOfFree
Method for the inhibition of function of STAT transcription... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Method for the inhibition of function of STAT transcription..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Method for the inhibition of function of STAT transcription... will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-3630397